Oncternal Therapeutics, Inc. of San Diego, CA, a company, filed a Form D amendment with the SEC on 2016-12-09. The offering totals $20.0M, of which $11.3M was reported sold. Industry: Biotechnology.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| Dana B McGowan | Executive Officer | San Diego, CA |
| Scott L Glenn | Director | Boulder, CO |
| Scott L Glenn | Executive Officer | Boulder, CO |
| Cam L Garner | Director | San Diego, CA |
| William R LaRue | Director | San Diego, CA |
| James B Breitmeyer, M.D., Ph.D. | Director | San Diego, CA |
| James B Breitmeyer, M.D., Ph.D. | Executive Officer | San Diego, CA |
| Lauren G Otsuki | Executive Officer | San Diego, CA |
| Richard R Vincent | Executive Officer | San Diego, CA |
| Cam R Gallagher | Director | San Diego, CA |
| Cooper R Collins | Director | San Diego, CA |
| Charles G Theuer, M.D. | Director | San Diego, CA |
| Cooper B Collins | Director | San Diego, CA |
| Brian B Lannutti | Executive Officer | San Diego, CA |
| Cam B Gallagher | Director | San Diego, CA |
| Langdon G Miller | Executive Officer | San Diego, CA |
| David F Johnson | Director | San Diego, CA |
| James G Freddo | Executive Officer | San Diego, CA |
| Brian F Lannutti | Executive Officer | San Diego, CA |
| Dana F McGowan | Executive Officer | San Diego, CA |
| Scott F Glenn | Director | San Diego, CA |
| Cam F Garner | Director | San Diego, CA |
| Karen F Lundgren | Executive Officer | Del Mar, CA |
| James L Freddo | Executive Officer | Del Mar, CA |
| Karen L Lundgren | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2018-11-21 | D | $24.0M | $17.0M |
| 2017-09-27 | D | $11.3M | $6.9M |
| 2017-03-23 | D/A | $23.5M | $17.9M |
| 2016-10-20 | D/A | $20.0M | $6.1M |
| 2016-07-08 | D | $3.3M | $150K |
| 2016-06-08 | D | $13.1M | $13.1M |
| 2016-03-10 | D/A | $10.0M | $3.7M |
| 2015-08-07 | D | $10.0M | $3.1M |
| 2014-03-05 | D | $3.3M | $3.1M |